Biomimetic Nanocarriers for Cancer Target Therapy
نویسندگان
چکیده
منابع مشابه
Trigger responsive polymeric nanocarriers for cancer therapy.
Conventional chemotherapy for the treatment of cancer has limited specificity when administered systemically and is often associated with toxicity issues. Enhanced accumulation of polymeric nanocarriers at a tumor site may be achieved by passive and active targeting. Incorporation of trigger responsiveness into these polymeric nanocarriers improves the anticancer efficacy of such systems by mod...
متن کاملNanocarriers for siRNA Therapy
Small interfering RNAs (siRNAs) therapy has opened exceptional advantageous opportunity for the treatment of diseases. Usually naked siRNA are subjected to internal harsh environment and rapidly degraded by RNases after administration. To overcome this issue various nanodelivery platforms have been developed and utilized in drug delivery due to narrowed size distribution, improved bioavailabili...
متن کاملDesign and bioinformatics analysis of novel biomimetic peptides as nanocarriers for gene transfer
Objective(s): The introduction of nucleic acids into cells for therapeutic objectives is significantly hindered by the size and charge of these molecules and therefore requires efficient vectors that assist cellular uptake. For several years great efforts have been devoted to the study of development of recombinant vectors based on biological domains with potential applications in gene therapy....
متن کاملNovel Drug Nanocarriers for Cancer Therapy: Carbon Nanotubes
Prevalent cancer therapies generally fail due to the improvement of the multidrug resistance, resulting in poor patient prognosis and high morbidity. Nano-sized drug delivery systems provide opportunities to deliver and target the anti-cancer molecules selectively to cancer cells. Among the various nano-sized drug carriers, carbon nanotubes (CNTs) have captivated the significant interest due to...
متن کاملThe Use of Nanocarriers for Drug Delivery in Cancer Therapy
Cancer treatment involving chemotherapy is typically accompanied by toxic side effects, thereby limiting the amount of the drug that can be given to a patient. As a result, all of the tumor tissue may not be exposed to a lethal dose of the drug. The use of nanocarriers such as liposomes and micelles can improve the pharmacological properties of traditional chemotherapeutics. Their small size (~...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Bioengineering
سال: 2020
ISSN: 2306-5354
DOI: 10.3390/bioengineering7030111